Showing results (11-20 of 616) with videos related to
Sort By:
Pageof 62
Diabetes/Metabolism Research and Reviews|June 5, 2009
Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose controlR P Radermecker, E Renard, A J ScheenRevue Medicale De Liege|August 2, 2008
[Statin for the brain: update in 2008]A J Scheen, R P Radermecker, B SadzotRevue Medicale De Liege|May 2, 2003
[How I treat...severe hypoglycemia in a diabetic patient]R P Radermecker, J C Philips, A J ScheenRevue Medicale De Liege|September 7, 2004
[Optimizing the managment of patients with diabetes mellitus: selected clinical trials from the 2004 Congress of the American Diabetes Association]A J Scheen, R P Radermecker, J C PhilipsRevue Medicale De Liege|November 24, 2004
[Effects of intensive insulin therapy after an acute myocardial infarction in patients with type 2 diabetes: results of the DIGAMI-2 trial]A J Scheen, R P Radermecker, J C PhilipsRevue Medicale De Liege|August 6, 2010
[Strategies avoiding inertia and non compliance in clinical trials]B J Jandrain, Ph Ernest, R P Radermecker, et al.Revue Medicale De Liege|May 2, 2003
[How I explore...glycemic kinetics by continuous glucose monitoring]R P Radermecker, D Magis, J L Sélam, et al.Revue Medicale Suisse|September 28, 2007
[Incretin mimetics and incretin enhancers for the treatment of type 2 diabetes]A J Scheen, R P Radermecker, J C Philips, et al.Revue Medicale De Liege|December 20, 2005
[Insulin detemir (Levemir)]A J Scheen, R P Radermecker, J C Philips, et al.Revue Medicale Suisse|October 7, 2011
[Renal SGLT2 inhibitors, new agents for the management of type 2 diabetes]A J Scheen, R P Radermecker, P Ernest, et al.Pageof 62